Target intelligence / Profile preview

AT-rich DNA region

Molecular classification
Other
01

Overview

AT-rich DNA regions are segments of the genome with a high proportion of adenine and thymine bases. These regions are recognized as functionally significant, particularly as DNA unwinding elements at origins of replication in both prokaryotic and eukaryotic genomes, where local destabilization of the double helix facilitates the initiation of DNA replication[2]. AT-rich sequences are also commonly found at nucleosome-free regions, such as promoters, where they recruit chromatin remodelers and contribute to transcription regulation[3]. In eukaryotes, tissue-specific genes tend to be more AT-rich and are typically found in condensed chromatin, in contrast to gene-dense, GC-rich housekeeping regions[4]. While not a discrete molecular target like a protein or defined receptor, AT-rich DNA serves as a structural and regulatory element in DNA. It can form non-canonical DNA structures (e.g., cruciforms)[7], participate in protein-DNA interactions (such as with TATA-binding protein)[1], and modulate gene expression. Errors or instability in AT-rich regions can result in genomic instability, increasing susceptibility to diseases like cancer[4]. These regions do not function as a traditional therapeutic target (e.g., enzyme, receptor) but present important biological features critical for DNA replication, transcription, and genome architecture[2][3][7].

Other names
AT-rich DNAA/T-rich DNA sequenceDNA unwinding element (DUE)poly(dA:dT) tracts
02

Biological functions

Replication origin activity (as DNA unwinding elements)Chromatin remodelingFormation of nucleosome-free regionsRegulation of gene expressionGenome organization
03

Disease associations

Cancer (through genome instability)Other (roles in maintaining genome integrity, potential impact in various diseases due to chromatin structure changes)
04

Safety considerations

Genomic instability (long palindromic AT-rich regions can promote DNA breaks)Increased mutation rates in AT-rich genes may contribute to disease (e.g., cancer)

Beyond the preview

Go deeper on AT-rich DNA region.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AT-rich DNA region.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call